Monthly Archives: February 2016

Featured Stories

Johnson & Johnson’s Ethicon Division to End Sales of Gynecare Prolift, Three Other Transvaginal Mesh Devices

Johnson & Johnson’s Ethicon Inc. division revealed yesterday that it will end sales of its Gynecare Prolift device and three other transvaginal mesh products. The plan to stop selling the four products was set forth in a letter filed by the company in the Ethicon transvaginal mesh multidistrict litigation ...

Read More

Study Suggests Hormonal Contraceptives Linked to Brain Tumor

Study Suggests Hormonal Contraceptives Linked to Increased Brain Tumor Risk

A study of Danish women of reproductive age suggests that long-term use of hormonal contraceptives is associated with an increased risk of brain tumors.

Read More

Research Study Confirms Fracking Cause of Ohio Earthquakes

Research Study Confirms Fracking as Cause of Ohio Earthquakes

Fracking operation near Poland Township, Ohio, activated a previously unknown fault in the, causing 77 earthquakes with magnitudes ranging from 1.0 to 3.0 in March 2014.

Read More

Bayer Yaz, Yasmin Blood Clot Lawsuit Settlements Stand at $147 Million

Bayer AG reported yesterday that it continues to settle Yaz and Yasmin birth control pill lawsuits. According to a report from Bloomberg News, the company said in its latest Stockholder Newsletter that it has settled 651 Yaz and Yasmin blood clot lawsuits for a total of $147 million. The average ...

Read More

DePuy ASR Hip Implants, Other Faulty Medical Devices Subject to Little FDA Oversight, Investigation Finds

A newly-published investigation from ProPublica has revealed that several questionable types of medical devices, including DePuy Orthopaedic’s recalled ASR hip implant, managed to make it to market without much scrutiny on the part of the U.S. Food & Drug Administration (FDA).

Read More

Actos Whistleblower Lawsuit Questions Avandia Researcher's Financial Ties to Takeda

A prominent researcher has been implicated in an alleged cover-up of Actos side effects, according to a report from TheHeart.org. An Actos whistleblower lawsuit unsealed earlier this year has alleged financial connections between the Cleveland Clinic’s Dr Steven Nissen and the maker of Actos “should be considered when analyzing Actos’s ...

Read More

Louisiana Whistleblower Lawsuit Revived

Louisiana Whistleblower Lawsuit Revived

A state appeals court in Louisiana has ruled that a former employee of Rapides Parish Coliseum can proceed with a whistleblower lawsuit against the Coliseum Authority.

Read More

Canadian Warning Issued for Actos Bladder Cancer Side Effect Risk

Health Canada has become the most recent national drug regulator to issue a warning about Actos and bladder cancer. Last month, the agency warned that interim results from a 10-year-study indicated that patients taking Actos for more than a year faced an increased risk of bladder cancer. Health Canada also ...

Read More

Study Links Liquid in E-Cigarette to Viral Infections

Study Links Liquid in Electronic Cigarette to Increased Risk of Viral Infections

The National Jewish Health study, links the liquid used in e-cigarettes to a higher risk of respiratory viral infections, whether the liquid contains nicotine or not.

Read More

Two Men Found Dead of Carbon Monoxide Poisoning

Two Men Found Dead of Carbon Monoxide Poisoning at Long Island, New York Auto Shop

Two men were found dead of apparent carbon monoxide poisoning in a Holbrook, New York, auto-detailing shop Thursday night, Suffolk County police say.

Read More

Harness Problem Prompts Recall of More than 56,000 Child Safety Seats

The baby and child product company Evenflo has recalled more than 56,000 child safety seats because in one of its modes, the child can loosen the internal harness, and will not be properly secured in the seat, increasing the risk … Continue reading

Posted in Defective Products, Product Recalls |

Blood Pressure Drugs May be Harmful for Type 2 Diabetes Patients

For some patients with type 2 diabetes, intense blood-pressure-lowering medication may do more harm than good, according to a new study published in the BMJ. Antihypertensive medication may raise the risk of cardiovascular death for some people with type 2 … Continue reading

Posted in Health Concerns, Pharmaceuticals |

Testimony Continues in DePuy Pinnacle Bellwether Trial

A bellwether trial happening in the Northern District of Texas is focusing on injuries allegedly caused by the DePuy Orthopaedics Pinnacle metal-on-metal hip implant. The outcome of this trial could affect many other pending Pinnacle lawsuits. The plaintiffs allege the … Continue reading

Posted in Defective Medical Devices, Depuy, Health Concerns, Metal Hip Implants |

Increased Dementia Risk Linked to Heartburn Drugs Linked to Use of Proton Pump Inhibitors for Heartburn

New research suggests that the use of certain drugs for gastric reflux or peptic ulcers creates an increased risk for dementia in elderly patients. The class of drugs—proton pump inhibitors (PPIs)—includes Prevacid (lansoprazole), Nexium (esomeprazole), and Prilosec (omeprazole), HealthDay reports.

Posted in Defective Products, Health Concerns, Nexium, Pharmaceuticals, Proton Pump Inhibitors |

FDA Urges Hospitals to Stop Using Custom Ultrasonics Duodenoscope Cleaning Machines

The Food and Drug Administration (FDA) has taken new steps in its efforts to deal with a series of superbug infections linked to the duodenoscope, a device used to examine the intestinal tract to diagnose and treat conditions including gallstones. … Continue reading

Posted in Defective Medical Devices, Duodenoscope, Health Concerns |

FDA Expected to Announce Results of Essure Investigation

A number of women are awaiting an announcement from the U.S. Food and Drug Administration (FDA) regarding Essure, a permanent birth control device sold by Bayer. The agency is expected to release the results of its investigation, which was launched … Continue reading

Posted in Legal News |

Legislators and 9/11 First Responders Ring Closing Bell at Stock Exchange to Celebrate Reauthorization of Zadroga Act

On Monday, February 22, 2016, U.S. Representatives Carolyn B. Maloney, Jerrold Nadler, and Dan Donovan joined 9/11 survivors and responders to ring the closing bell at the New York Stock Exchange in honor of the reauthorization of the James Zadroga … Continue reading

Posted in Health Concerns, Toxic Substances |

CDC Warns of Greater Health Risks with Lumber Liquidators Laminate Flooring than Earlier Thought

Some types of laminate flooring made by Lumber Liquidators pose a greater risk of causing cancer or other health problems than previously announced, according to the Centers for Disease Control and Prevention (CDC). The CDC said people who purchased Lumber Liquidators … Continue reading

Posted in Defective Products, Health Concerns, Toxic Substances |

$72 Million Verdict in Talcum-Powder Related Ovarian Cancer Death

A jury in St. Louis has awarded $72 million to the family of an Alabama woman who died from ovarian cancer she said was caused by using Johnson & Johnson’s baby powder and other products containing talcum. This civil suit … Continue reading

Posted in Defective Products, Health Concerns, Legal News |

Jury Returns $72 Million Verdict against Johnson & Johnson in Talcum Powder Related Ovarian Cancer Death

A jury in St. Louis jury returned a $72 million dollar verdict on February 22, 2016 in the case of a woman who died of ovarian cancer. The jury found the cancer was caused by her use of talc-based products … Continue reading

Posted in Health Concerns, Legal News |

© 2005-2019 Parker Waichman LLP ®. All Rights Reserved.